HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 4, 2923-2930, January 25, 2002

This Article Full Text Full Text (PDF) All Versions of this Article: 277/4/2923    most recent M109113200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hwang, S. G. Articles by Choe, J. Search for Related Content PubMed PubMed Citation Articles by Hwang, S. G. Articles by Choe, J. Social Bookmarking                      What's this?

Human Papillomavirus Type 16 E7 Binds to E2F1 and Activates E2F1-driven Transcription in a Retinoblastoma Protein-independent Manner^*

Sun Gwan Hwang, Daeyoup Lee, Jiyun Kim, Taegun Seo, and Joonho Choe

From the Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Korea

The human papillomavirus (HPV) E7 oncoprotein can immortalize primary human cells and induce tumor formation. These properties of E7 depend on its ability to inhibit the activity of retinoblastoma protein (pRB), which in turn affects E2F function. E2F proteins control the expression of genes involved in differentiation, development, cell proliferation, and apoptosis. By using genetic and biochemical approaches, the present study shows that E7 binds to E2F1 in vivo and in vitro and that both proteins co-localize in the nucleus. Importantly, the binding of the high risk group HPV E7 to E2F1 is tighter than the binding of the low risk group HPV E7 to E2F1. Although E7 of the high risk group HPVs activates E2F1-dependent transcription strongly in C33A or 293T cells, E7 of the low risk group HPVs activates transcription only weakly. By using electrophoretic mobility shift assay, we also showed that E7 binds to E2F1-DNA complexes. Furthermore, we show that these activities of E7 are independent of pRB by using E7 and E2F1 mutants that cannot bind to pRB. Taken together, these data suggest that E7 contributes to the deregulation of pRB-dependent E2F1 repression and to the further activation of E2F1 independently of pRB.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. E. McLaughlin-Drubin, K.-W. Huh, and K. Munger Human Papillomavirus Type 16 E7 Oncoprotein Associates with E2F6 J. Virol., September 1, 2008; 82(17): 8695 - 8705. [Abstract] [Full Text] [PDF]

				S. Balsitis, F. Dick, N. Dyson, and P. F. Lambert Critical Roles for Non-pRb Targets of Human Papillomavirus Type 16 E7 in Cervical Carcinogenesis Cancer Res., October 1, 2006; 66(19): 9393 - 9400. [Abstract] [Full Text] [PDF]

				X. Liu and R. Marmorstein When viral oncoprotein meets tumor suppressor: a structural view Genes & Dev., September 1, 2006; 20(17): 2332 - 2337. [Full Text] [PDF]

				X. Liu, A. Clements, K. Zhao, and R. Marmorstein Structure of the Human Papillomavirus E7 Oncoprotein and Its Mechanism for Inactivation of the Retinoblastoma Tumor Suppressor J. Biol. Chem., January 6, 2006; 281(1): 578 - 586. [Abstract] [Full Text] [PDF]

				C. Lim, T. Seo, J. Jung, and J. Choe Identification of a virus trans-acting regulatory element on the latent DNA replication of Kaposi's sarcoma-associated herpesvirus J. Gen. Virol., April 1, 2004; 85(4): 843 - 855. [Abstract] [Full Text] [PDF]

				H. T. Kang, J. W. Ju, J. W. Cho, and E. S. Hwang Down-regulation of Sp1 Activity through Modulation of O-Glycosylation by Treatment with a Low Glucose Mimetic, 2-Deoxyglucose J. Biol. Chem., December 19, 2003; 278(51): 51223 - 51231. [Abstract] [Full Text] [PDF]